Skip to content

The Warren Center for Neuroscience Drug Discovery is staffed by dozens of scientists who bring industry experience to this collaborative, academic setting. Since 2007, WCNDD has made noteworthy progress in finding treatments for neurological disorders such as schizophrenia, Parkinson’s disease and movement disorders and Alzheimer’s disease.

The WCNDD is led by Director, Craig Lindsley. Dr. Lindsley is the William K. Warren Jr. Chair in Medicine and University Distinguished Professor of Pharmacology, Chemistry and Biochemistry at Vanderbilt University. Dr. Lindsley brings over 25 successful years of drug discovery and development experience from Merck and Eli Lilly. He currently serves as the Editor-in-Chief for the Journal of Medicinal Chemistry.

Testimonial Photo@2x

Craig Lindsley, Executive Director, Warren Center for Neuroscience Drug Discovery and AD3 instructor

 

Vanderbilt University

School of Medicine Basic Sciences

school-of-medicine-building

The Vanderbilt University School of Medicine Basic Sciences is a leading center for discovery science, advancing fundamental insights that power the development of new therapeutics and technologies to improve human health.

With a strong emphasis on translational research, Basic Sciences brings together expertise across disciplines to accelerate the path from early discovery to drug development. Through close integration with centers like the Warren Center for Neuroscience Drug Discovery, the school fosters an environment where foundational science is directly connected to real-world impact.

Guided by core values of scientific excellence, collaboration, integrity, and mentorship, the School of Medicine Basic Sciences is consistently ranked among the nation’s top institutions in NIH funding, reflecting the strength of its contributions to biomedical innovation.

Group 661@2x

FAQs

Ready to drive the future of drug discovery?

Please fill out the form below to learn more about the Applied Drug Discovery & Development (AD3) Certificate.